INSM Chief Legal Officer sells 1,806 shares
INSMED Inc Chief Legal Officer Michael Alexander Smith sold 1,806 shares of Common Stock in an open-market transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
INSMED Inc Chief Legal Officer Michael Alexander Smith sold 1,806 shares of Common Stock in an open-market transaction. The shares were sold at a price of $95.82 per share. After this sale, he directly holds 37,648 shares of INSMED Inc Common Stock.
The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025, which means the timing and amount were set in advance rather than decided at the moment of sale.
Insider Trade Summary 10b5-1
Net Seller: 1,806 shares
Net Sell
1 txn
Insider
Smith Michael Alexander
Role
Chief Legal Officer
Sold
1,806 shs ($173K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,806 | $95.82 | $173K |
Holdings After Transaction:
Common Stock — 37,648 shares (Direct)
Footnotes (1)
- F1. This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Key Figures
Shares sold: 1,806 shares
Sale price per share: $95.82 per share
Shares owned after sale: 37,648 shares
+1 more
4 metrics
Shares sold
1,806 shares
Open-market sale of Common Stock
Sale price per share
$95.82 per share
Price for the 1,806-share sale
Shares owned after sale
37,648 shares
Direct holdings following transaction
Net shares sold
1,806 shares
Net selling activity in this Form 4
Key Terms
Rule 10b5-1, open-market sale, Common Stock, Form 4
4 terms
Rule 10b5-1 regulatory
"in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
""security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did INSM (INSMED Inc) disclose in this Form 4?
INSMED Inc disclosed that Chief Legal Officer Michael Alexander Smith completed an open-market sale of 1,806 shares of Common Stock at $95.82 per share. Following this transaction, he directly holds 37,648 shares of the company’s Common Stock.
Who is the insider involved in the latest INSM Form 4 filing and what is his role?
The insider is Michael Alexander Smith, who serves as Chief Legal Officer at INSMED Inc. He reported an open-market sale of 1,806 shares of Common Stock and now directly owns 37,648 shares after the reported transaction.
Was the INSM insider sale executed under a Rule 10b5-1 trading plan?
Yes. The filing states the transaction was effected under a Rule 10b5-1 trading plan adopted on November 7, 2025. Such plans pre-schedule trades, meaning timing and share amounts are set in advance under predetermined instructions.
What does the transaction code in the INSM Form 4 indicate about this trade?
The Form 4 shows transaction code "S," described as a sale in an open market or private transaction. Combined with the provided description, it confirms this was an open-market sale of 1,806 INSMED Inc Common Stock shares at $95.82 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates